CSI Market
Sign In | Register

Lunai Bioworks Inc (LNAI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access LNAI quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Lunai Bioworks Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
12 Months 		(Jun 30 2024) (Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Operating Activities
Income-178.01
Depreciation & amortization0.13
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges170.42
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Accretion Of Discount-
Loss On Forgiveness On Note Receivable-
Gain On Forgiveness Of Debt Related Party-
Change In Consideration Of Contingent Consideration Liability-
Change In Contingent Consideration Liability-
Gain Loss On Sale Of Accounts Receivable-
Change In Unrealized Gain Loss On Fair Value Hedging Instruments-
Non Cash Compensation-
Finance Lease Right Of Use Asset Amortization-
Change In Fair Value Of Contingent Consideration-11.68
Loss On Extinguishment Of Debt-
Restricted Shares For Services Rendered-
Amortization Of Discount On Note Payable0.03
Increase Decrease In Operating Lease Liability-0.02
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables1.15
Increase (Decrease) in Accounts Payable3.11
Increase (Decrease) in Other Accrued Liabilities0.50
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.14
Other Working Capital-0.03
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities5.37
Discontinued operations0.00
Net Cash flow from Operating Activities-7.87
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Net Increase In Cash Held In Escrow-
Net Increase Decrease In Cash Held In Escrow-
Payments To Acquire Equity Securities Fv Ni-0.50
Sale Of Equitable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.50
Financing Activities
Short-term debt Net6.98
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.38
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Expense Paid By Related Party On Behalf Of The Company-
Common Stock Subscribed-
Net Proceeds From Advances To Purchase Common Shares-
Repayment Of Finance Agreement-
Proceeds From Direct Offering Net Of Issuance Costs-
Proceeds From Lpc Equity Agreement-
None-
Repayments Of Finance Agreement-0.97
Proceeds From Atm Offering Net Of Issuance Costs-
Proceeds From Subscription Payable-
Repayment Of Notes Payable-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities8.38
Effect of exchange rate on cash flow-0.14
Discontinued operations0.00
Free Cash Flow-7.87
Total Cash Flow-0.13
4 historic quarters locked

Sign in to unlock the full Lunai Bioworks Inc cash flow history.

Sign In Create Free Account

About Lunai Bioworks Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20250630)
  • Filed with the SEC: September 29, 2025
  • Source: e6882_10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001731122-25-001316

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License